MOI)ERATOR POLLACK: This panel was
designed to try to answer some of the questions that are being raised today in connection with the subject of the etiology of atherosclerosis. Cardiologists have been so concerned with the diagnosis and treatment of clinical cardiologic disorders up to fairly recently that they did not have time to occupy themselves with the etiology of one of the principal causes of myocardial disease, that is atherosclerosis.
The reopening of this question of the etiology of atheroselerosis has been rather bewildering because it brings up new terminologies and technies foreign to the electronic principles that have engaged many of the clinical cardiologists. They have been forced to listen to such terminology as poly-unsaturated fatty acids, iodine numbers, beta sitosterol, and many other names that are new in the cardiologic literature.
Another new aspect of this subject has been the epidemiologic one. Here again the cardiologrist as a rule has not kept pace with the development of epidemiologic technics, the study of the community as a whole rather than the patient as an individual.
To start the panel today. I should like to ask Dr. Herman JE. Hilleboe W\e must use indirect methods of study.
Consequently it is necessary for us to talk about associations and degrees of associationls and not about cause and effect. Certainly our work with tuberculosis seemed complex, even though we knew the cause was the tuberele bacillus and we could classify pulmonary lesions as minimal, moderate, and far advanced. We cannot do this clinically with atherosclerosis, which manifests itself in the heart and brain and in the peripheral circulation. I think that we need not know the cause of diseases in order to do somnethinlg about them. If we can learn enough about their epideniologic characteristics to detect their occurrence early and to prevent their progression then public health workers and private practitioners can proceed collectively to do something about them.
PANEL DISCUSSION
The biggest criticism that we would make of some of the work going on-and I hope that this is considered as constructive criticismis that we are dealing with diseases difficult to define. In the literature and in the work that is done, we find that defining coronary artery disease itself or the manifestations of atherosclerosis are in quite a confused state. We find that in the living individual, because of the difficulty of determining the incubation period of coronary artery disease, we are at a loss to study its natural history. We know, too, that postmortem studies present difficulties in classification.
In addition, as we view some of the studies throughout the world on the natural history of atherosclerosis we find great difficulty in bridging the gaps that occur. Specifically in coronary artery disease we think first of the diet itself, the components of the diet, particularly fat, the fat content of the blood, the fat composition of the arteries in which we are particularly interested, and the terminal episode.
It is very easy to relate the diet to several constituents in the blood. We cannot by inference jump from the relationship between these 2 things to the relationship between the constituents in the blood and the cause of impairment and death. Our greatest gap occurs at this point.
As epidemiologists we start out initially by studying the principal factors. For example, in coronary atherosclerosis we are interested in any relationships that there might be between the available food, as for example the fat in the diet, and death from various types of coronary artery disease or associated heart conditions. It is easy to select a half dozen countries and to show a linear relationship between the available fat in the dietary of the countries and the mortality from arteriosclerotic heart disease. But if we look more extensively into the available food and the mnortality from heart disease, we at once learn that the picture is not so simple as it might appear.
The first comment that I would make as anl epidemiologist is that we must not alter the facts that should be considered before constructing a hypothesis that we will try to prove.
It has been shown by a study of the data from as many as 22 countries that if we review the figures concerning the available food supplies and the mortality, the apparent association observed when applied to a limited number of countries is greatly reduced; also that the basic data are subject to considerable limitations. This caution applies both to the components of the diet in the different countries and to the mortality, especially to the classifications of causes of death. In addition the presumed association is not specific for fats in the diet nor for diseases of the heart. For instance, the association of mortality from heart disease with diet is stronger when the correlation is with animal protein. There could isolate from the atheroma resembled in general the composition of the serum. These observations wcre followed by the classic experiments that showed that by feeding cholesterol to rabbits experimnental atherosclerosis could be induced. Since this time the preoccupation of the biochemists with the idea that atheroselerosis is a disorder of lipid metabolism has increased. The search for truth has opened up in a marvelous way many avenues of research, including the establishment of new technics which I think are going to revolutionize the biochemists' concept of fat metabolism, such as column chromatography, gas phase chromatography, and many other technics that have attracted a number of workers in this field.
I think it would be amiss to be so preoccupied in the field of lipid metabolism to believe that it is the only factor involved in the pathogenicity of atheroselerosis. The weight of my remarks will be directed toward the idea that we must not lose sight of many other factors involved in the pathogenesis of this disease, some of them certainly completely nonlipoidal and foreign to the area of fat metabolism.
Taking a lead from Dr. Hilleboe's discussion of the epidemiology, I will consider the triangle which the epidemiologist deals with in the general analysis of infectious disease. lie relates by a triangle the host, the environment, and the agent. The problem with atheroselerosis is that the agent is not easy to find. It may not exist as a single entity, but certainly we can say that circumstances which lead to the formation of atheroma arise by interaction between host and environment. The agent is endogenous. To complicate the picture further we (can add those factors that seem to bear some relationship to the progress of atherosclerosis ill the host: heredity, race, age, sex, endocrine glands, and even the psyche. The To highlight this multiple etiology further 1 relate diet, which is so widely discussed today, to clinical events that can be measured by the clinician or the epidemiologist. Between these 2 determinants there lies a tenuous route of association possibly because I am going from diet, to serum lipids, to the process of atherogenesis, and then to the clinical event. We know that this line of association is not a direct line, and the length and strength of the connectionls cannot be precisely defined at the present time for a population or for an individual.
We have to recognize that the effect of diet -and the caloric balance, the protein intake, the fat intake, the carbohydrate intake, and possibly even the mineral and the vitamin intake-may have some influence not only upon serum lipids but upon other events in this chain, and we have to recognize other factors operating at each level to produce this disease.
In discussing this problem I refer to the multiple factors even at the site of intqeraction between beta lipoproteins and serum. You will agree that there may also be a determiiant in the process of atheromatosis in the artery itself.
One We cannot with this evidence make a 1: 1 relation between serum fat and clinical disease. It is interesting, however, that many of the subjects with infarets seem to cluster above the midpoint, between the 50 and the 75 percentile of the serum cholesterol distribution curve; this distribution confirms the fact that the serum profile is one determinant of atherosclerosis but its quantitative significance in a given individual, or even a given population, in my opinion has yet to be evaluated.
I present what is a reasonable summary of our concepts of fat metabolism at the present time relating to 3 organs, the gut as the site of absorption, the liver which serves as the site of transformation, and the depots which serve as the site of storage. The fat that is absorbed by the gut passer to the liver and the other tissue, and the liver transforms this chyle in large amounts to lipoproteins, etc.
Further, we know that in certain cases, such as diabetic acidosis and in starvation and in certain pituitary disorders, the depots can mobilize a great amount of lipid, for example, ehylomicromis, and transform it to beta lipoproteins, and the response is often an increasing output of beta lipoproteins. I would like to call your attention to the liver, possibly a central organ in mediating the response of depots of fatty acids mobilized in various ways; also the liver may have an important influence in transforming dietary modifications of the lipoprotein profile.
In conclusion, I would say that at the present time the physiologist should look upon-I think is compelled to look upon-atheroselerosis as a disease of multiple etiology in which disorders of lipid metabolism may play a role. Secondly, beta lipoproteins appear to be a determinant in the process of atherogenesis but their quantitative significance is yet to be precisely evaluated. Third, dietary manipulations can alter the serum cholesterol and lipoprotein configuration. The extent to which this happens in individual cases and in individual populations in the presence of varying components of diet other than fat is still a subject for investigation.
Finally, I would make the plea that every physician taking care of middle-aged patients LIPID METABOLISM AND ATHEROSCILjEROSIS consider himself a clinical investigator in this particular period when data are needed about the relationship of the diet and of the lipid levels and of the natural history of atherosclerosis, to define the problem further so that some reasonable position at the public health level can be taken.
MODERATOR The variable course of this disease is one of the problems that is sometimes forgotten, and in too small a group of patients, particularly patients who are followed without adequate controls, I think that we get utterly and totally lost. This is particularly true of small groups that are treated by physicians in the office and in clinic and hospital practice, where the relatively good outlook over a short period of time would make one consider that one is getting satisfactory results.
Just to remind you how variable is this disease with its remissions and exacerbations, I will present very simply the course of a few )atients illustrating sonie aspects of this fact.
First is an individual going from 1944 with a course that is nowe actually associated with less angina than he had for a period of many years. Next is another individual who 21 years ago had his first infarct, which is well documented. He had another infarct, a ventricular aneurysm, and advanced angina decubitus; and he is now free of angina. Next is an individual who has gone along with essentially the same amount of symptomatology for a period of 12 years.
We are deluding ourselves if we think of this disease as being either a malignant disease with a standard predictable progression or that it is a disease with a standard stable course. It is neither, and it will take a good many cases, followed over a good many years, by each of us, before we can get satisfactory data regarding the course of the disease and the effect obtained by any agent.
Finally, I would like to remind this audience that all of us who see patients are having difficulties with the publicity that attends the subject of fat in the diet. If the American public has a weakness, it certainly has a weakness for going into a panic at certain times. You will remember the mock invasion from Mars that struck New York some years ago when everybody headed for the hills. I think that maybe Sputnik has had a similar effect on the American public. The medical litera-ture and the drug literature relating to the subject of fats and cholesterol, and the papers you have heard here today, all serve to create a wave of public interest that creates a problemn in the hospital, in the clinic, and in the office. It requires patience and conservatism to withstand the onslaught of patients, press, radio, and television, and to withstand the temptation to make a dogmatic statement and to give treatment with a certainty not justified.
MODERATOR POLLACK: The panel will now entertain and invite questions from the floor for further discussion.
While we are waiting for some of the people in the audience to gather their thoughts, Dr. Hilleboe, I would like to ask you if you would care to comment briefly as to whether or not we are running into an increasing epidemic of coronary heart disease.
DR. HILLEBOE: This question must take into consideration several factors. First of all, we have an aging population and, as you know, with an aging population we have more disease of various types, including atherosclerosis and its various manifestations. So corrections must be made for the change in the age and sex distribution of our population.
Secondly, we must recall that in 1949 there was a change in the nomenclature of the disease, and that if we attempt to make studies of long-term trends of the disease going from a period of time at the turn of the twentieth century to the present we must have an adjustment at 1949, because we called coronary artery disease one thing before that time and another thing after that time.
Thirdly, we know that within the short space of the last 10 years there has been quite a change in the accuracy and the completeness of the diagnosis of coronary heart disease. I happen to serve oii one of the advisory coinmittees to the National Office of Old Age and Survivors' Insurance, and twice a year we review some of the samples of diagnoses received from physicians. Some of them have been made by older physicians, middle-aged physicians, and recent graduates, and certainly the types of conditions that are called coronary heart disease are legion, because we go all the way from simple angina to the classical picture with changes ili the electrocardiogram and changes in the x-ray, with the history and physical findings and other laboratory findings.
So these are the factors that we must comisider when we judge whether or not there has been an increase in coronary artery disease. I would say offhand that the increase has been more apparent than real. The extent to which it has increased is modified by the factors that I have mentioned. Properly considered they show that there has been not quite as proportionately great an increase as one would suspect from a cursory examination of recent figures.
MODERATOR POLLACK: Dr. Paul, you were talking about the distribution of atheroselerotic lesions in the body. Would you mind commenting on why the pulmonary tree is free from atherosclerosis? DR. PAUL: Of course, atherosclerotic lesions can occur in the pulmonary circulation where pulmonary hypertension exists. Under normal circumstances, however, the pressure in the pulmonary artery is about one quarter or less than that in the peripheral circulation and the mean pressure is similarly lower. So we have normally a difference in lateral pressure on the vessel wall in the two circulations, which is at least a partial explanation of this freedom from atherosclerosis in the pulmonary vascular bed. When the pulmonary artery has been subjected to increased pressure, atherosclerotic plaques may develop. MODERATOR POLLACK: In all of this discussion the word vitamins has not been introduced. I cannot think of any discussion on nutrition that does not involve vitamins. Dr. Olson, do you want to discuss the role of vitamin B6 or pyridoxine in atheroselerosis? DR. OLSON: There is some good evidence on the subject and some additional speculation. We know from the work of several laboratories that vitamin B6 deficiency in the primate-in the monkey-can cause atheromatous lesions in the large vessels and in the coronary arteries of that species. These are characterized more by intimal proliferation than by fatty infiltration or deposits in the intima. In fact, in the B.>6 deficient monkey the serum lipids are quite low.
We also know that niacin at high levels does affect the serum cholesterol level. I am sure that the mechanism of this effect is familiar to pharmacologists. It is not nutritional in the sense of the usual intake of this vitamin, but it provides another interesting problem.
MODERATOR POLLACK: All of which raises the question, Dr. Paul, what would your recommendation be with respect to some of these preparations on the market now that are mixtures of the poly-unsaturated fatty acids and pyridoxine, vitamin B6, etc With that preface, I would say that in my mind the problem again is centered at the individual patient-doctor level at the present time.
In our own clinic we are studying several combinations of diet therapy for patients with clinical evidence of atherosclerosis. My own feeling is that the evidence today suggests that the unsaturated fats provide the best avenue of diet therapy for controlling serum cholesterol. In our clinic we are studying the effect of incorporating unsaturated fat in various proportions with saturated fat at a level of about 40 per cent of the calories in diets that will maintain weight in these patients. But, as I say, this problem is unsettled and I think it is premature to say without further evidence of this kind, which we all should participate in, that this course or that course is the preferred one for prevention of further progress of this disease.
DR. HILLEBOE: We attempt to approach something of this kind on the basis of the best advice we can get from the experts. By the experts we mean the cardiologists, the laboratory people, the epidemiologists-anyone who can contribute to basic knowledge for the control of a chronic disease. Our problem amounts to working with the state and the local medical societies in putting out health information that people understand and with which we have some hope of succeeding in affecting the population.
When we use these two means in an attempt to get people to cut down the fat in their diets we fail in both of them. DR. PAUL: I think that when we use the term coronary atheroselerosis we are using it interchangeably with the general term used in the standard nomenclature, arteriosclerotic heart disease and that is what we are referring to.
DR. HILLEBOE: The chairman has presented a question to me that really covers a lot of territory. Before I answer it I want to know whether you want to hear it. I will read the question and if you want to hear something about it, I will be glad to tell you. If you do not think it is pertinent, say so. This is the question from the audience, " Wouldn 't the Public Health Service be doing a more efficient job if they disseminated information to the press regarding a weight reduction program for the obese rather than spending so much time on the Asian flu problem?" (Applause) I take it for granted that you are clapping for the person who posed the question.
MODERATOR POLLACK: If there is no further discussion, we will terminate this part of the program.
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